GS/Fut8 Knockout Cell Line-CHO-K1

GS/Fut8 Knockout Cell Line-CHO-K1

Cat.No. : CSC-RT0097

Host Cell: CHO-K1 Target Gene: GS and Fut8

Size: 1x10^6 cells/vial, 1mL Validation: Sequencing

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Cat. No. CSC-RT0097
Cell Line Information CHO-K1-GS/Fut8 cell line is a stable cell line with a double homozygous knockout of GS and Fut8.
Target Gene GS and Fut8
Gene ID 100689337;100751648
Genotype GS (-/-) and Fut8 (-/-)
Host Cell CHO-K1
Size 1x10^6 cells/vial, 1mL
Sequencing Result GS: 32 bp deletion in allele 1 and allele 2
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Media Type Cell were cultured in RPMI 1640 supplemented with 10% fetal bovine serum.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 70-80% confluency, approximately 1:4-1:8.
Freeze Medium Complete medium supplemented with 10% (v/v) DMSO
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Inquiry

Background

Applications

Glutamine synthetase (GS), also known as glutamine ammonia ligase, is a key enzyme in amino acid metabolism. It catalyzes the ATP-dependent conversion of glutamate and ammonia to glutamine, one of the 20 standard amino acids used in protein synthesis. This reaction not only produces glutamine, an important metabolite involved in various physiological processes, but also plays an important role in the detoxification of ammonia, a potential byproduct of cellular metabolism. Many studies have linked GS dysregulation to pathological conditions, highlighting the importance of this enzyme. In hepatic encephalopathy, decreased GS activity is associated with elevated blood ammonia levels, leading to neurological dysfunction. In cancer, GS is often upregulated in tumor cells, providing them with the necessary glutamine to promote anabolic growth and proliferation. Fucosyltransferase 8 (FUT8) is an enzyme encoded by the FUT8 gene and is a member of the glycosyltransferase family. It catalyzes the transfer of fucose, a hexose, from GDP-fucose to the innermost N-acetylglucosamine (GlcNAc) residue of N-glycans to form core fucosylation. This specific modification plays a key role in the structural and functional diversity of glycoproteins. FUT8 is essential in various biological processes, such as cell signaling, cell adhesion, and immune responses. The activity and expression levels of this enzyme are tightly regulated, and any alterations can have profound physiological consequences. FUT8 dysregulation has been implicated in a variety of pathological conditions, including cancer, inflammation, and innate diseases. In cancer, aberrant core fucosylation is often associated with tumor progression and metastasis.
GS/Fut8 Double Knockout Cell Line - CHO-K1 is a Chinese Hamster Ovary cell line that has been genetically engineered to lack the glutamine synthetase (GS) and fucosyltransferase 8 (Fut8) genes. This unique cell line has a wide range of applications in biopharmaceutical research and production, especially in the development of therapeutic proteins and monoclonal antibodies. Glycoprotein Production: The CHO-K1 GS/Fut8 Knockout cell line facilitates the production of glycoproteins with precisely tailored glycosylation profiles for a variety of therapeutic proteins. Antibody Development: By removing fucose residues, this cell line enhances antibody-dependent cellular cytotoxicity (ADCC), making it valuable for the development and production of more effective monoclonal antibodies for cancer therapy. Protein Characterization: Researchers use this cell line to study the functional role of fucosylation in various biologics, facilitating structural and functional analysis of fucose-free proteins. Biosimilar Manufacturing: This cell line facilitates the production of biosimilars that closely resemble the glycosylation pattern of their target biologic, ensuring efficacy and safety. Pathway Analysis: It serves as a model to study cellular pathways affected by the absence of the Fut8 enzyme, providing insights into complex biochemical networks.

For research use only. Not intended for any clinical use.
CBpromise   

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER